Mesoprefrontal cortical dopaminergic activity and prefrontal hypofunction in schizophrenia
- PMID: 1498953
- DOI: 10.1097/00002826-199201001-00296
Mesoprefrontal cortical dopaminergic activity and prefrontal hypofunction in schizophrenia
Similar articles
-
Dopamine and the neural circuitry of primate prefrontal cortex: implications for schizophrenia research.Neuropsychopharmacology. 1992 Feb;6(2):127-34. Neuropsychopharmacology. 1992. PMID: 1610486 Review.
-
Mesocortical dopaminergic function and human cognition.Ann N Y Acad Sci. 1988;537:330-8. doi: 10.1111/j.1749-6632.1988.tb42117.x. Ann N Y Acad Sci. 1988. PMID: 2974264 Review.
-
Dopamine, the prefrontal cortex and schizophrenia.J Psychopharmacol. 1997;11(2):123-31. doi: 10.1177/026988119701100205. J Psychopharmacol. 1997. PMID: 9208376 Review.
-
Mesocortical neurotensin/dopamine system: is it involved in the pathogenesis of schizophrenia?Jpn J Psychiatry Neurol. 1991 Jun;45(2):503-6. doi: 10.1111/j.1440-1819.1991.tb02533.x. Jpn J Psychiatry Neurol. 1991. PMID: 1722262 No abstract available.
-
Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity.Arch Gen Psychiatry. 1988 Jul;45(7):616-22. doi: 10.1001/archpsyc.1988.01800310020002. Arch Gen Psychiatry. 1988. PMID: 3382321
Cited by
-
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.NeuroRx. 2006 Jan;3(1):106-16. doi: 10.1016/j.nurx.2005.12.004. NeuroRx. 2006. PMID: 16490417 Free PMC article. Review.
-
Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.JAMA Psychiatry. 2015 Apr;72(4):316-24. doi: 10.1001/jamapsychiatry.2014.2414. JAMA Psychiatry. 2015. PMID: 25651194 Free PMC article.
-
Estimates of projection overlap and zones of convergence within frontal-striatal circuits.J Neurosci. 2014 Jul 16;34(29):9497-505. doi: 10.1523/JNEUROSCI.5806-12.2014. J Neurosci. 2014. PMID: 25031393 Free PMC article.
-
Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.CNS Drugs. 2007;21(7):535-57. doi: 10.2165/00023210-200721070-00002. CNS Drugs. 2007. PMID: 17579498 Review.
-
The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention.Schizophr Bull. 2019 Jan 1;45(1):148-157. doi: 10.1093/schbul/sbx199. Schizophr Bull. 2019. PMID: 29385549 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical